Stryker to Acquire Amplitude Vascular for $835M to Boost Vascular Tech

Stryker has announced a definitive agreement to acquire Amplitude Vascular Systems in a deal valued at up to $835 million. According to reports, the acquisition aims to integrate proprietary hydraulic intravascular lithotripsy technology into Stryker's peripheral vascular portfolio. This move is designed to bolster the company's offerings in treating peripheral arterial disease through next-generation medical technology.

This acquisition places Stryker in direct competition with major medical device peers such as Boston Scientific and Shockwave Medical (recently acquired by Johnson & Johnson). Per market data, the intravascular lithotripsy segment continues to see robust growth due to rising demand for minimally invasive procedures. Stryker's recent quarterly performance showed strong revenue momentum in its MedSurg and Neurotechnology units, providing a solid foundation for this capital allocation.

Investors are monitoring SYK stock performance following the announcement, focusing on how the acquisition costs will impact near-term margins. According to the economic calendar, upcoming US Producer Price Index (PPI) data remains a key macro catalyst for the healthcare sector. Market participants will also watch for further details regarding the regulatory approval timeline and the expected closing date of the transaction.